Aarkstore Enterprise-Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs

Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs


The leading business intelligence provider, has released its latest research, “Biomarkers In Drug Discovery - Optimizing Drug Discovery Timeline and Costs”. The report provides an in-depth analysis of the potential applications of biomarkers in pharmaceutical drug discovery and clinical services. This pharmaceutical and healthcare report suggests investment decisions in biomarker-based drug research by providing information on valid biomarkers, pipelines, case studies, competitive landscape, geographical trends, mergers and acquisitions and market potential. It also provides an analysis on the trends prevailing in the global biomarkers market. In addition to this, the report covers drivers and restrains for the global biomarkers market.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

The scope of this report includes:
- Market Potential and Pipeline Analysis of biomarkers by phase of development, therapeutic class and geography.
- Market Size and forecast of global biomarkers market and biomarkers drug discovery market from 2000 to 2008, forecast forward to 2015.
- Analysis of Key geographies including the US (United States), Europe the UK (United Kingdom), France, Germany, Italy and Spain), Australia and Southeast Asia.
- Investments and Funding Analysis for top companies (Quest Diagnostics, Applied Biosystems, Vermillion, BGMedical, Menarini, Abbott, Roche, Genetech, Affymetrix and Amgen) in the biomarker-based assay development arena. This includes biomarker research on the application and development of novel biomarkers by the top companies and analysis of the competitive factors affecting the global biomarkers market.
- Qualitative analysis of market drivers, market trends, and challenges.
- M&A landscape in the biomarkers space segmented by deal value, geography and phase.



For more information, please contact :
http://www.aarkstore.com/reports/Biomarkers-in-Drug-Discovery-Optimizing-Drug-Discovery-Timeline-and-Costs-37289.html

Related Reports

Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies

Cell-Based Assays for Drug Discovery

The Drug Discovery Outsourcing Market

Innovative Drug Discovery in Emerging Markets

TOP 10 DRUG DISCOVERY TECHNOLOGIES – STRATEGIC ANALYSIS AND GLOBAL FORECASTS

Drug Discovery Collaborations between Academia and the Pharmaceutical Industry: Cultural factors, intellectual property considerations, case studies, and future trends

How IT Helps Solve Pharma's R&D Problems: in silico Drug Discovery

Outsourcing in Drug Discovery: The Contract Research Organization

Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 4th Edition

The Future of GPCRs in Drug Discovery: Novel technologies, leading companies, and opportunities for target expansion
Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs

Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting

Preclinical Models: Innovative solutions to accelerate drug discovery and development

DNA Sequencing In Drug Discovery: Market outlook for applications, tools and services, and 40 company profiles

Contact : Minu
Aarkstore Enterprise
Tel : +912227453309
Mobile No: +919272852585
Email :contact@aarkstore.com
Website : http://www.aarkstore.com
Blog:http://www.emarketreports.com

Was this helpful? 0 0 Comments

Did this article Aarkstore Enterprise-Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs solve your question / problem? If not, read following similar tutorials & articles or ask a new question.

• Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs - Aarkstore Enterprise?

  Aarkstore announce a new report "Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs" through its vast collection of market research report.

You're reading Aarkstore Enterprise-Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs.